Atjaunināt sīkdatņu piekrišanu

E-grāmata: Managing Drugs in Sport [Taylor & Francis e-book]

(University of New South Wales, Australia)
Citas grāmatas par šo tēmu:
  • Taylor & Francis e-book
  • Cena: 160,08 €*
  • * this price gives unlimited concurrent access for unlimited time
  • Standarta cena: 228,69 €
  • Ietaupiet 30%
Citas grāmatas par šo tēmu:
As recent high-profile drugs scandals have demonstrated, sport organisations rarely have a coherent, meaningful, long-term management strategy regarding drug use and abuse. Typically, sport managers hope drug problems never happen and engage in damage control when they do. This important new book argues that drugs in sport must be seen as a legitimate management issue; that the reality is that athletes will use and misuse drugs, and that sport managers require a sophisticated understanding of this issue to enable them to develop effective strategies and responses.

Drawing on cutting-edge management theory, the book explores the characteristics of drugs in sport as another aspect of managerial life. It offers a broad-ranging introduction to the policy and business contexts that have shaped responses to the issue of drugs in sport, and examines the significance of this issue in functional areas of sport management such as human resource management, marketing, risk management, and entrepreneurialism. The book discusses practical management concerns, such as managing sport science programs and working with anti-doping organisations, and offers clear recommendations for the future management of sport.

This is the first book to offer a complete framework for engaging with drugs in sport as both a management and integrity issue, and is important reading for all advanced students, researchers and practitioners working in sport management, sport business, sport policy, sport governance, or business ethics.
Acknowledgements x
PART I Context
1(72)
1 Managing integrity in sport: the case of drug control
3(15)
Managing drugs and integrity: corporate social responsibility
4(7)
The role of anti-doping
11(2)
How sport manages drugs in sport -- structure of the book
13(5)
2 The role of drugs in sport
18(16)
Defining the first dimension: drugs
18(1)
Defining the second dimension: use, misuse and abuse
19(2)
Drugs and sport
21(1)
The sports drug matrix
21(8)
Implications of the sports drug matrix for managing drugs in sport
29(5)
3 The evolution of drug control for sport
34(21)
From ancient times to the Renaissance
34(1)
Pre-industrial drug control
35(1)
The emergence of modern sport
36(1)
Industrialisation
37(1)
The emergence of drug control for sport
38(1)
Post-war drug control: the war on drugs
39(1)
The war on drugs in sport begins
40(4)
Tobacco sponsorship: sport continues to lose the initiative
44(1)
Lost initiative: drug scandals and reactionary crisis management
45(1)
Regaining the initiative: the rise of anti-doping
46(2)
Post anti-doping
48(1)
Potentially losing the initiative in the future
49(1)
Conclusion
50(1)
Addendum
50(5)
4 Policy context for managing drugs in sport
55(18)
The anti-doping policy
55(3)
Critiques of the anti-doping policy
58(4)
Status of the anti-doping policy
62(1)
Alternatives to the anti-doping policy
63(6)
Drug control policy alternatives for sport
69(4)
PART II Management
73(100)
5 Drug control and the business of sport
75(14)
Structure of the sports industry
75(5)
Competing interests
80(2)
Revenue
82(4)
The business of managing drugs in sport
86(3)
6 Business ethics and drug control for sport
89(19)
Virtues and the Spirit of Sport
90(4)
A different virtues approach to drug control for sport
94(5)
Virtues and drug control for sport
99(1)
Extending the debate to other ethical perspectives
99(4)
Kick starting the business ethics of drug control for sport
103(5)
7 Governance of drugs in sport
108(17)
Systemic governance of anti-doping
109(6)
Organisational governance of anti-doping
115(6)
The good and bad of governance for drugs in sport
121(4)
8 Managing drug risks in sport
125(14)
Drug risks
125(6)
Managing risks from doping and anti-doping
131(4)
Managing the integrity risks of drugs in sport
135(4)
9 Human resources and drugs in sport
139(18)
Front line HRM responses to drugs in sport
139(4)
CSR, strategic HRM and drugs in sport
143(9)
Linking CSR and the HRM of drugs in sport
152(5)
10 Marketing, integrity management and drugs in sport
157(16)
Daniel Prior
Marketing of licit drugs in sport
158(4)
Drug scandals in sport
162(3)
Anti-doping as marketing
165(3)
Marketing drugs and integrity in sport
168(5)
PART III Drug control-led integrity management
173(44)
11 Managing drugs beyond elite male sport
175(20)
Managing drugs in women's sport
175(4)
Managing drugs in children's sport
179(5)
Managing drugs in non-elite sport
184(4)
Drug control for all sport
188(7)
12 Second generation drug control for sport
195(14)
Harm-minimisation
195(1)
Implementation of harm-minimisation
196(6)
Harm-minimisation and the challenges of anti-doping
202(1)
Potential wicked problems for harm-minimisation
203(3)
Second generation drug control for sport and sports integrity
206(3)
13 Reflections on sport, drugs and integrity management
209(8)
Has anti-doping worked?
209(3)
Integrity management
212(2)
Personal reflections on sports, drugs and integrity
214(2)
Conclusions on drugs, sport and integrity
216(1)
Index 217
Jason Mazanov is a Senior Lecturer in the School of Business, UNSW-Canberra, Australia. He is a registered psychologist whose primary work has been explaining drug use, particularly the use of performance enhancing substances. He is the founding editor (with Professor Frances Quirk) of the journal Performance Enhancement and Health, has 38 peer-reviewed publications, and teaches organisational behaviour, leadership and human resource management to masters level